SIRT1 and glucose metabolism disease: SIRT1 and SIRT3 are key melatonin targets; in rats, melatonin efficiently alleviates glucose metabolism disorders by decreasing mitochondrial dysfunction through activating SIRT1 and SIRT3 (Chen et al., 2019; Zhang et al., 2017).